Seroba Life Sciences — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Shorla Oncologyshorlaoncology.comin𝕏Oct 2023 · $35M
Shorla Oncology develops and commercializes oncology drugs for indications where existing treatments are limited, in shortage, or inadequate for the target population.
BiotechHealthtech
Co-investorsKurma PartnersEnterprise Ireland
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.